Sera Prognostics Inc., a Salt Lake City-based company focused on improving maternal and neonatal health through innovative precision biomarker approaches, has appointed Jay M. Moyes as chief financial officer. Moyes has more than two decades of experience in C-level executive and board positions of both private and public companies. Moyes’ experience includes serving as chief financial officer and director of Amedica Corp. and as CFO at XDx. He also led the finance function for 14 years at Myriad Genetics, including serving as its CFO. He currently serves as director on the public boards of Achieve Life Sciences, BioCardia and Puma Biotechnologies. Previous roles include board director service with Predictive Technology Group, Osiris Therapeutics and Integrated Diagnostics.